# Liver Function After Intravenous Methylprednisolone Administration

> **NCT03667157** · PHASE4 · COMPLETED · sponsor: **Medical University of Warsaw** · enrollment: 68 (actual)

## Conditions studied

- Graves Disease
- Graves Ophthalmopathy
- Liver Diseases
- Liver Failure
- Liver Injury
- Liver Dysfunction
- Liver Insufficiency
- Acute Liver Failure
- Acute Liver Injury
- Acute Liver Injury, Drug Induced
- Methylprednisolone Adverse Reaction
- Glucocorticoids Toxicity
- Dysthyroid Orbitopathy
- Dysthyroid Ophthalmopathy

## Interventions

- **DRUG:** every week IVMP therapy
- **DRUG:** very high doses IVMP therapy

## Key facts

- **NCT ID:** NCT03667157
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-01
- **Primary completion:** 2016-10-30
- **Final completion:** 2016-10-30
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03667157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03667157, "Liver Function After Intravenous Methylprednisolone Administration". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03667157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*